Litigation
Apr. 11, 2015
Allergan drops insider trading claims against Valeant
The legal battle between Allergan Inc., Valeant Pharmaceuticals International Inc. and Pershing Square Capital Management LP, came to a close Thursday, putting an end to nearly a year of hostilities.
Daily Journal Staff Writer
The legal battle between Allergan Inc., Valeant Pharmaceuticals International Inc. and Pershing Square Capital Management LP, came to a close Thursday, putting an end to nearly a year of hostilities stemming from Valeant and Pershing Square's attempted hostile takeover of the Irvine-based Botox maker.
Both sides have agreed to voluntarily withdraw all claims against each other and will pay their ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In